TerSera Therapeutics Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- TerSera Therapeutics's estimated revenue is currently $13.1M per year.
- TerSera Therapeutics's estimated revenue per employee is $120367
- TerSera Therapeutics has 109 Employees.
- TerSera Therapeutics grew their employee count by 51% last year.
- TerSera Therapeutics currently has 1 job openings.
|Lora Blackowicz||Vice President, Pharmacovigilance|
|Rick Crowley||Executive Vice President, Operations and Quality Assurance|
|Kenton Morneau||VP Information Technology|
|Vicky Papoutsis||EVP Business Development|
|Taryn Stinson||Director, Marketing|
|John Flood||Executive Director of Sales/National Accounts|
|Marcy Komocsar||Executive Director, Clinical and Pharmacovigilance|
|Tom McGrady||Vice President Quality Assurance|
|Dyer Vann||Director of Marketing|
What Is TerSera Therapeutics?
TerSera Therapeutics acquires and develops specialty pharmaceutical products with a focus on select therapeutic areas. Our mission is to market products which truly make a difference for patients. Our focus is to bring intelligent solutions to prescribers and patients who need better solutions. We deliver a comprehensive set of programs that go beyond the therapy itself in order to provide improved outcomes for patients.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Care One Pharma...||$6.4M||39||22%|
|Firma Clinical ...||$14.3M||78||0%|
TerSera Therapeutics News
Goserelin Market SWOT Analysis including key players AstraZeneca, TerSera Therapeutics, Luye Pharma A Comprehensive Study exploring ...
Meloxicam Drug Market Latest Trend with Top key players: Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung ...
Plenty of Opportunities in Meloxicam Drug Market Studied in Detail along with Top Companies as Boehringer-Ingelheim, TerSera Therapeutics, ...